6CM
683 Capital Management Portfolio holdings
AUM
$986M
1-Year Est. Return
26.79%
1 Year Est. Return
+26.79%
AUM
$986M
AUM Growth
+$309K
(+0.03%)
Holding
146
Top Buys
| 1 | +$28.6M | |
| 2 | +$19.9M | |
| 3 | +$14.6M | |
| 4 |
Sarepta Therapeutics
SRPT
|
+$8.72M |
| 5 |
Eli Lilly
LLY
|
+$7.99M |
Top Sells
| 1 | +$27.3M | |
| 2 | +$20.1M | |
| 3 | +$17.1M | |
| 4 |
Baidu
BIDU
|
+$16.3M |
| 5 |
Ero Copper
ERO
|
+$12.7M |
Sector Composition
| 1 | Healthcare | 33.92% |
| 2 | Consumer Discretionary | 14.4% |
| 3 | Financials | 11.94% |
| 4 | Industrials | 10.63% |
| 5 | Materials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
Baidu
BIDU
$44.4B
| – | – |
-177,500
|
|
||
127
Coinbase
COIN
$95.7B
| – | – |
0
|
|
||
128
DHT Holdings
DHT
$2.03B
| – | – |
-150,000
|
|
||
129
Galapagos
GLPG
$2.06B
| – | – |
-110,100
|
|
||
|
HES
130
DELISTED
Hess
HES
| – | – |
-107,295
|
|
||
131
Hims & Hers Health
HIMS
$11.1B
| – | – |
0
|
|
||
132
Insmed
INSM
$34.5B
| – | – |
0
|
|
||
133
IonQ
IONQ
$22.1B
| – | – |
0
|
|
||
134
Iovance Biotherapeutics
IOVA
$836M
| – | – |
-2,400,000
|
|
||
|
ITOS
135
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-1,750,000
|
|
||
136
KBR
KBR
$5.6B
| – | – |
-131,000
|
|
||
137
Leidos
LDOS
$24.2B
| – | – |
-43,000
|
|
||
138
Strategy Inc
MSTR
$85.8B
| – | – |
0
|
|
||
|
MTA
139
Metalla Royalty & Streaming
MTA
$638M
| – | – |
-109,080
|
|
||
140
Nuvation Bio Inc Warrants
NUVB.WS
$61.2M
| – | – |
-335,754
|
|